Your browser doesn't support javascript.
loading
High-dose-rate stereotactic body radiation therapy for postradiation therapy locally recurrent prostatic carcinoma: Preliminary prostate-specific antigen response, disease-free survival, and toxicity assessment.
Fuller, Donald B; Wurzer, James; Shirazi, Reza; Bridge, Stephen S; Law, Jonathan; Mardirossian, George.
Afiliação
  • Fuller DB; Department of Radiation Oncology, Genesis Healthcare Partners, Inc., San Diego, California. Electronic address: dfuller@genhp.com.
  • Wurzer J; Department of Radiation Oncology, Atlanticare, Egg Harbor, New Jersey.
  • Shirazi R; Department of Radiation Oncology, Genesis Healthcare Partners, Inc., San Diego, California.
  • Bridge SS; Department of Urology, Genesis Healthcare Partners, Inc., San Diego, California.
  • Law J; Department of Radiation Oncology, Atlanticare, Egg Harbor, New Jersey.
  • Mardirossian G; Department of Radiation Oncology, Genesis Healthcare Partners, Inc., San Diego, California.
Pract Radiat Oncol ; 5(6): e615-23, 2015.
Article em En | MEDLINE | ID: mdl-26059509

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Etiology_studies / Prognostic_studies Limite: Aged / Aged80 / Humans / Male / Middle aged Idioma: En Ano de publicação: 2015 Tipo de documento: Article